• Technology and Data
  • Front End Sales and Marketing
  • Allergy
  • HIV
  • Women's Health
  • Migraine
  • Compounding
  • Continuous Glucose Monitoring
  • Mental Health Awareness
  • Veterinary Pharmacy
  • CBD
  • Infectious Disease
  • Eye Health
  • Digestive Health
  • Biosimilars
  • Influenza
  • Shingles
  • COPD Management
  • Pediatrics
  • Generics
  • Pain Management
  • COVID-19
  • Immunization
  • Oncology
  • Anticoagulants
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Respiratory
  • Heart Health
  • Cardiovascular Clinical Consult

Follow-up care for survivors of breast and prostate cancer


Breast cancer has been diagnosed and treated in approximately 2 million women living in the United States, and the incidence of prostate cancer—now second in prevalence to lung cancer in men—has shown a slow but steady increase.1 Cancers of the breast and prostate are hormone-dependent, and this has been the focus of intense research that has resulted in the new, effective adjuvant therapies that are in use today.

Related Content
© 2023 MJH Life Sciences

All rights reserved.